A new strategy for the therapy of pancreatic cancer invasion and metastasis by protease inhibitor and protein pump inhibitor agents

Japanese Journal of Gastroenterological Surgery

Volumn 29, Issue 4, 1996, Pages 888-892

  Ohta, Tetsuo ^a   Nakagawara, Hisatoshi ^a   Arakawa, Hajime ^a   Futagami, Fumio ^a   Tsukioka, Yuji ^a   Kitagawa, Hirohisa ^a   Kayahara, Masato ^a   Nagakawa, Takukazu ^a   Miyazaki, Istuo ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Bafilomycin A1; Pancreatic cancer; Vacuolar type H+ ATPase

Indexed keywords

EID: 2642677657     PISSN: 03869768     EISSN: None     Source Type: Journal    
DOI: 10.5833/jjgs.29.888     Document Type: Article

References (9)

1. +-ATPase. J Bioenerg Biomembr 21 : 553-571, 1989
2. Hasegawa Y, Takada M, Yamamoto M et al : The gradient of basic fibroblast growth factor concentration in human pancreatic cancer cell invasion. Biochem Biophys Res Comm 200 : 1435-1439, 1994
3. Ohta T, Terada T, Nagakawa T et al : Expression of pancreatic trypsinogen in human extrapancreatic gastrointestinal carcinomas. Oncol Rep 1 : 759-764, 1994
4. Ogawa M, Tomita N, Hori A et al : Pancreatic secretory trypsin inhibitor in cancers. Adv Exp Med Biol 240 : 547-553, 1988
5. +-ATPase in the rufled borders of osteoclasts. J Biol Chem 265 : 7645-7654, 1990
6. Figarella C, Miszczuk-Jamska B, Barrett AJ : Possible lysosomal activation of pancreatic zymogens. Biol Chem Hoppe Seyler 369 : 293298, 1988